This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ahlam N Qerqez: Innovator in Engineered T-Cell Receptors
Introduction
Ahlam N Qerqez is a notable inventor based in Cedar Park, TX (US). He has made significant contributions to the field of immunology through his innovative work on engineered T-cell receptors. His research focuses on targeting cytomegalovirus (CMV) infected cells, which is crucial for advancing therapeutic strategies.
Latest Patents
Ahlam N Qerqez holds a patent for "High Affinity Engineered T-Cell Receptors Targeting CMV Infected Cells." This patent represents a significant advancement in the development of targeted immunotherapies, showcasing his expertise and dedication to improving patient outcomes.
Career Highlights
Qerqez is affiliated with The University of Texas System, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to revolutionize treatments for viral infections, particularly in immunocompromised patients.
Collaborations
Ahlam collaborates with Ellen Wagner, a fellow researcher, to further explore the applications of engineered T-cell receptors. Their partnership exemplifies the collaborative spirit of scientific research, driving innovation in the field.
Conclusion
Ahlam N Qerqez is a pioneering inventor whose work on engineered T-cell receptors is paving the way for new therapeutic approaches. His contributions to immunology are invaluable, and his ongoing research promises to make a lasting impact in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile